AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

Investing at least part of the initial $1,000 in an artificial intelligence (AI) stock is a smart move. Despite impressive ...

The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures to diseases like cancer and antibiotic-resistant infections. Australian ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Slashing adverse drug reactions through pharmacogenetics and advanced AI could help rehabilitate the pharmaceutical ...

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C.

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

Keith Shaw: Counterfeiting is no longer just about luxury goods or fake currency. It’s now infiltrating areas like ...

The pharmaceutical supply chain has entered a new era—one defined not just by compliance and safety, but by digital agility, ...

Rakovina Therapeutics Inc. ('Rakovina” or the 'Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next ...

The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in ...